These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19766052)

  • 21. Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines.
    Galonić DP; Gin DY
    Nature; 2007 Apr; 446(7139):1000-7. PubMed ID: 17460660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoconjugates in cancer therapy.
    Cipolla L; Peri F; Airoldi C
    Anticancer Agents Med Chem; 2008 Jan; 8(1):92-121. PubMed ID: 18220509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors.
    Ingale S; Wolfert MA; Buskas T; Boons GJ
    Chembiochem; 2009 Feb; 10(3):455-63. PubMed ID: 19145607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
    Wu J; Guo Z
    Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valency and density matter: Deciphering impacts of immunogen structures on immune responses against a tumor associated carbohydrate antigen using synthetic glycopolymers.
    Qin Q; Yin Z; Wu X; Haas KM; Huang X
    Biomaterials; 2016 Sep; 101():189-98. PubMed ID: 27294537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.
    Zhu J; Warren JD; Danishefsky SJ
    Expert Rev Vaccines; 2009 Oct; 8(10):1399-413. PubMed ID: 19803761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.
    Song C; Zheng XJ; Liu CC; Zhou Y; Ye XS
    Oncotarget; 2017 Jul; 8(29):47330-47343. PubMed ID: 28537884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
    Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
    Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens.
    Allen JR; Harris CR; Danishefsky SJ
    J Am Chem Soc; 2001 Mar; 123(9):1890-7. PubMed ID: 11456809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
    Beckwith DM; Cudic M
    Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From synthesis to biologics: preclinical data on a chemistry derived anticancer vaccine.
    Zhu J; Wan Q; Lee D; Yang G; Spassova MK; Ouerfelli O; Ragupathi G; Damani P; Livingston PO; Danishefsky SJ
    J Am Chem Soc; 2009 Jul; 131(26):9298-303. PubMed ID: 19518111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
    Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
    ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cancer therapeutic vaccine based on clustered Tn-antigen mimetics induces strong antibody-mediated protective immunity.
    Richichi B; Thomas B; Fiore M; Bosco R; Qureshi H; Nativi C; Renaudet O; BenMohamed L
    Angew Chem Int Ed Engl; 2014 Oct; 53(44):11917-20. PubMed ID: 25168881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate vaccines as immunotherapy for cancer.
    Slovin SF; Keding SJ; Ragupathi G
    Immunol Cell Biol; 2005 Aug; 83(4):418-28. PubMed ID: 16033538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.
    Qiu L; Li J; Yu S; Wang Q; Li Y; Hu Z; Wu Q; Guo Z; Zhang J
    Oncotarget; 2015 Mar; 6(7):5195-203. PubMed ID: 25760071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies.
    Zhang J; Terreni M; Liu F; Sollogoub M; Zhang Y
    Biomed Pharmacother; 2024 Jul; 176():116824. PubMed ID: 38820973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient metabolic engineering of GM3 on tumor cells by N-phenylacetyl-D-mannosamine.
    Chefalo P; Pan Y; Nagy N; Guo Z; Harding CV
    Biochemistry; 2006 Mar; 45(11):3733-9. PubMed ID: 16533056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
    De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
    J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.